Fig. 2

Multimodal imaging of the affected eye in case 2. a. Fundus photography showing infra-temporal RAM with surrounding stellate-shaped exudates involving the fovea at the baseline visit. b. OCT angiography showing the heliciform capillary mass in the RAM in the superficial layer at the baseline visit. c. Corresponding image showing the OCT B-scan lines. d. OCT scan showing SRD in the macular area at the baseline visit. e. Fundus photography showing the absorption of the hemorrhage and the remaining white fibrosis and hard exudates involving the fovea one month after the first injection. f. OCT angiography showing the regression of the heliciform capillary mass in the RAM in the superficial layer one month after the first injection. g. Corresponding image showing the OCT B-scan lines. h. OCT scan showing disappeared SRD in the macular area one month after the first injection. i. Fundus photography showing resolved hard exudates one month after the second injection. j. OCT angiography showing the further regression of the heliciform capillary mass in the RAM in the superficial layer one month after the second injection. k. Corresponding image showing the OCT B-scan lines. l. CT scan through the fovea showing total resolution of SRD one month after the second injection. m. Fundus photography showing no hemorrhage and only white fibrosis (arrow) in the inferior-temporal artery at the one-year follow up. n. OCT angiography showing the absence of the capillary mass at the one-year follow up. o. Corresponding image showing the OCT B-scan lines. p. OCT scan showing normal macular appearance without SRD at the one-year follow up